Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

Most of the biosynthetic gene clusters (BGCs) found in microbes are silent under standard
laboratory cultivation conditions due to the lack of expression triggering stimuli, representing a …

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host …

The investigation of neurodegenerative diseases advanced significantly with the advent of
cell-reprogramming technology, leading to the creation of new models of human illness. …

Astrogliosis and microglial reactions are correlated with the formation of scar tissue and
synapse loss. 4‐hydroxy‐tempo (TEMPOL) is a reactive oxygen species scavenger with proven …

The COVID-19 pandemic was initiated by the rapid spread of a SARS-CoV-2 strain. Though
mainly classified as a respiratory disease, SARS-CoV-2 infects multiple tissues throughout …

COVID-19 patients may exhibit neuropsychiatric and neurological symptoms. We found that
anxiety and cognitive impairment are manifested by 28-56% of SARS-CoV-2-infected …

Background There is mounting evidence that SARS-CoV-2 targets tissues beyond the
respiratory tract. Long-term sequelae after COVID-19 are frequent and of major concern. …

Schizophrenia is a complex and heterogeneous neurodevelopmental psychiatric disorder
characterized by a variety of symptoms classically grouped into three main domains: positive (…